Exploring the Evidence: Is Intravenous Ascorbic Acid An Effective and Safe Option For Increasing Hemoglobin Levels In Patients with a Hyporesponse To Epoetin Alfa?

Exploring the Evidence: Is Intravenous Ascorbic Acid An Effective and Safe Option For Increasing Hemoglobin Levels In Patients with a Hyporesponse To Epoetin Alfa?


Identification: nnj_maD4
Issue: March-April 2012
Volume: Vol. 39, No. 2

Standard: $30.00

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content

References